MedTrace Logo

ANRS 12392 Sanu Gundo

NCT04482010 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2021-02-25

No results posted yet for this study

Summary

Sanu Gundo ANRS 12392 is a non-randomized and non-comparative intervention trial in Mali.

The main objective of the project is to study the feasibility of the community-based HIV care in the context of the artisanal gold mining zones and to evaluate its contribution to the linkage-to-care of PLWHIV with the health system and their retention in care, as well as its effect on their health status.

Conditions

  • HIV Infections

Interventions

OTHER

Local community-based HIV care

Compared to the classic HIV care, community-based HIV care includes: * Individual interviews with a psychosocial agent; * Support groups conducted by psychosocial agents; * Culinary workshops gathering PLWHIV and healthcare professionals; * Home visits by a community worker; * Emergency relief based on a funding for patients with urgent needs As in the classic HIV care, ARCAD Santé PLUS provides consultations with doctors, prescriptions and delivery of antiretroviral (ARV) treatment every 3 months, biological analyses for enrolment, and follow-up every 6 months. In addition, psychosocial agents from ARCAD Santé PLUS propose workshops on education and support for adherence to treatment.

Sponsors & Collaborators

  • UMR 1252 SESSTIM

    collaborator UNKNOWN

  • ARCAD Santé PLUS

    collaborator UNKNOWN

  • SEREFO

    collaborator UNKNOWN

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Luis Sagaon Teyssier, PhD · UMR1252 SESSTIM (INSERM, IRD, Aix Marseille Université)

  • Bintou Dembélé Keïta, MD · ARCAD Santé PLUS

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-29
Primary Completion
2022-03-28
Completion
2022-12-28

Countries

  • Mali

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04482010 on ClinicalTrials.gov